IPSEN SA News

Gilead Wins FDA Nod for Liver Disease Drug

Seeking AlphaAug 14 14:25 ET

Gilead Exits J&J Royalty Deal for Liver Drug Ahead of Potential FDA Nod

Seeking AlphaAug 10 08:13 ET

IPSEN - Buy-back Programme - Art 5 of MAR - Week 30 - 2024

Yahoo FinanceJul 30 12:00 ET

Ipsen Liver Disease Drugs Endorsed in EU

Seeking AlphaJul 26 10:31 ET

Ipsen S.A. Non-GAAP EPS of €4.78, Revenue of €1.66B; Raises FY24 Outlook

Seeking AlphaJul 25 03:47 ET

IPSEN - Buy-back Programme - Art 5 of MAR - Week 28 - 2024

Yahoo FinanceJul 16 12:00 ET

Ipsen - June 2024 - Monthly Information Relative to the Total Number of Voting Rights and Shares Composing the Share Capital

Yahoo FinanceJul 9 12:00 ET

IPSEN - Buy-back Programme - Art 5 of MAR - Week 27 - 2024

Yahoo FinanceJul 9 12:00 ET

Hutchmed Gains as Ipsen-partnered Lymphoma Drug Undergoes Review in China

Seeking AlphaJul 5 13:41 ET

IPSEN - Buy-back Programme - Art 5 of MAR - Week 23 - 2024

Yahoo FinanceJun 11 12:00 ET

FDA Fast-Tracks Ipsen And Genfit's New Liver Disease Treatment, Iqirvo

BenzingaJun 11 09:18 ET

Ipsen's Approval Doesn't Come as a Surprise -- Market Talk

WSJJun 11 02:58 ET

Description of the Regulatory Framework of the Share Repurchase Program Proposed by the Board of Directors to Be Approved at Ipsen S.A.'s Annual General Meeting on 28 May 2024

Yahoo FinanceMay 28 01:00 ET

Ipsen S.A. Reports Q1 Results; Reaffirms Full-year Guidance

Seeking AlphaApr 24 02:26 ET

Ipsen - Monthly Information Relative to the Total Number of Voting Rights and Shares Composing the Share Capital

Yahoo FinanceApr 8 12:00 ET